Reuters logo
BRIEF-Shijiazhuang Yiling Pharma's subsidiary plans to boost capital of U.S. Unit
September 28, 2017 / 12:43 PM / 25 days ago

BRIEF-Shijiazhuang Yiling Pharma's subsidiary plans to boost capital of U.S. Unit

Sept 28 (Reuters) - Shijiazhuang Yiling Pharmaceutical Co Ltd

* Says subsidiary plans to boost capital of U.S. unit Yiling Pharmaceutical Inc to $16.8 million from $8.3 million

* Says it plans to issue up to 1.0 billion yuan commercial paper

Source text in Chinese: bit.ly/2hy3L21; bit.ly/2frY5SQ

Further company coverage: (Reporting by Hong Kong newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below